Clinical Trials · NCT01744236
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Amsterdam UMC, location VUmc
- Enrollment
- 70
- Start date
- Apr 2013
- Locations
- 1 site, Netherlands
- Primary endpoint
- Changes from baseline following infusion of GLP-1RA (acute effects) and the changes from baseline following 12-week treatment with GLP-1RA or DPP-4i (long-term effects) on resting heart rate variability, as derived from electrocardiographic measurements.